Company intelligence / Profile preview

Ikarovec

Colney/Norwich Research Park, Norfolk, United Kingdomikarovec.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Ikarovec has developed a unique bicistronic gene therapy approach targeting complex eye diseases such as AMD. Their preclinical data suggest superiority over current and in-development treatments. The company aims to provide a one-time treatment that could offer lifelong benefit and reduce the burden of frequent injections required by current standards of care. They have raised £8M in seed funding and are seeking Series A investment to advance into clinical trials.

Therapeutic areas
Ophthalmology
Modalities
Gene therapy
Industry
Biotech
02

Drug pipeline

4 assets

IKC-151V

Preclinical

3 more assets in the full pipeline.

Request access →
03

Partnerships

Rentschler Biopharma (for manufacturing/development support)LifeArcParkwalk AdvisersUKI2S as investors/partners supporting early development/funding rounds

Beyond the preview

Go deeper on Ikarovec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ikarovec.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call